← The Wire
PRLDNasdaq
Prelude Therapeutics Inc
Pharmaceutical Preparations · DE · CIK 1678660
Developing precision oncology medicines for unmet cancer needs using targeted protein degradation
red 8-K · 90d
$358M
Market cap
$4.93
Last close
+12.6%
1D
+14.1%
5D
478K
Volume
Price · last 39 sessions+4.0%
May 4L $3.50 · H $5.15Jun 29
121
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 10, 202610-Q10-QMay 12, 20268-KResults of Operations · Reg FD DisclosureMay 12, 2026DEFA14ADEFA14AApr 29, 2026DEF 14ADEF 14AApr 29, 2026SC 13D/ASC 13D/AApr 23, 2026SC 13D/ASC 13D/AApr 22, 20268-KMaterial Agreement · Company UpdateApr 21, 2026424B5424B5Apr 21, 20268-KReg FD Disclosure · Company UpdateApr 20, 20268-KExecutive ChangeApr 15, 20268-KCompany UpdateMar 12, 2026424B5424B5Mar 12, 202610-K10-KMar 10, 20268-KResults of Operations · Reg FD DisclosureMar 10, 20268-KReg FD DisclosureFeb 3, 20268-KReg FD DisclosureJan 9, 202610-Q10-QNov 12, 20258-KResults of Operations · Reg FD DisclosureNov 12, 20258-KExecutive Change · Material AgreementNov 4, 20258-KExecutive Change · Reg FD DisclosureOct 17, 20258-KCompany UpdateSep 19, 202510-Q10-QAug 14, 20258-KResults of Operations · Reg FD DisclosureAug 14, 20258-KExecutive Change · Shareholder VoteJun 13, 202510-Q10-QMay 6, 20258-KResults of Operations · Reg FD DisclosureMay 6, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KCompany UpdateApr 25, 20258-KDelisting NoticeMar 28, 202510-K10-KMar 10, 20258-KResults of Operations · Reg FD DisclosureMar 10, 20258-KExecutive ChangeFeb 5, 20258-KCompany UpdateDec 11, 202410-Q10-QNov 6, 20248-KResults of Operations · Reg FD DisclosureNov 6, 20248-KCompany UpdateOct 24, 20248-KCompany UpdateSep 13, 20248-KReg FD DisclosureSep 9, 202410-Q10-QAug 12, 20248-KResults of Operations · Reg FD DisclosureAug 12, 20248-KShareholder VoteJun 18, 20248-KReg FD DisclosureJun 12, 20248-K/AExecutive ChangeMay 16, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KExecutive ChangeApr 10, 202410-K10-KFeb 15, 20248-KResults of OperationsFeb 15, 20248-KMaterial Agreement · Equity IssuanceDec 11, 2023SC 13GSCHEDULE 13GNov 13, 202310-Q10-QNov 1, 20238-KResults of OperationsNov 1, 202310-Q10-QAug 3, 20238-KResults of Operations · Reg FD DisclosureAug 3, 20238-KShareholder VoteJun 21, 20238-KReg FD DisclosureJun 1, 2023424B5424B5May 19, 20238-KMaterial Agreement · Company UpdateMay 19, 2023424B5424B5May 17, 20238-KCompany UpdateMay 17, 202310-Q10-QMay 8, 20238-KResults of Operations · Reg FD DisclosureMay 8, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KMaterial AgreementMar 15, 2023424B5424B5Mar 15, 202310-K10-KMar 15, 20238-KResults of Operations · Reg FD DisclosureMar 15, 20238-KReg FD DisclosureFeb 14, 2023SC 13GSC 13GFeb 13, 20238-KBylaw AmendmentJan 23, 20238-KReg FD DisclosureJan 9, 202310-Q10-QNov 14, 20228-KResults of Operations · Reg FD DisclosureNov 14, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 9, 2022
Similar companies
Comparable business profile · signals at a glance